Human observers have optimal introspective access to perceptual processes even for visually masked stimuli
Abstract
Many believe that humans can 'perceive unconsciously' -- that for weak stimuli, briefly presented and masked, above-chance discrimination is possible without awareness. Interestingly, an online survey reveals that most experts in the field recognize the lack of convincing evidence for this phenomenon, and yet they persist in this belief. Using a recently-developed bias-free experimental procedure for measuring subjective introspection (confidence), we found no evidence for unconscious perception; participants' behavior matched that of a Bayesian ideal observer, even though the stimuli were visually masked. This surprising finding suggests that the thresholds for subjective awareness and objective discrimination are effectively the same: if objective task performance is above chance, there is likely conscious experience. These findings shed new light on decades-old methodological issues regarding what it takes to consider a neurobiological or behavioral effect to be 'unconscious,' and provide a platform for rigorously investigating unconscious perception in future studies.
Article and author information
Author details
Reviewing Editor
- Matteo Carandini, University College London, United Kingdom
Ethics
Human subjects: Twelve subjects (two women, ages 19-32, ten right-handed) gave written informed consent to participate in our behavioral experiments. All subjects had normal or corrected-to-normal eyesight, and wore the same corrective lenses for all sessions, if applicable. Behavioral experiments were conducted in accordance with the Declaration of Helsinki and were approved by the UCLA Institutional Review Board.Eighty-seven respondents replied to our informal online survey. Survey procedures were conducted in accordance with the Declaration of Helsinki and were approved by the UCLA Institutional Review Board.Thus, all survey respondents provided informed consent to participate in the informal online survey, and behavioral subjects provided written informed consent to participate in the behavioral experiments.
Version history
- Received: June 24, 2015
- Accepted: October 2, 2015
- Accepted Manuscript published: October 3, 2015 (version 1)
- Version of Record published: February 1, 2016 (version 2)
- Version of Record updated: March 31, 2016 (version 3)
Copyright
© 2015, Peters & Lau
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 6,159
- views
-
- 1,275
- downloads
-
- 90
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Neuroscience
Nociceptive sensory neurons convey pain-related signals to the CNS using action potentials. Loss-of-function mutations in the voltage-gated sodium channel NaV1.7 cause insensitivity to pain (presumably by reducing nociceptor excitability) but clinical trials seeking to treat pain by inhibiting NaV1.7 pharmacologically have struggled. This may reflect the variable contribution of NaV1.7 to nociceptor excitability. Contrary to claims that NaV1.7 is necessary for nociceptors to initiate action potentials, we show that nociceptors can achieve similar excitability using different combinations of NaV1.3, NaV1.7, and NaV1.8. Selectively blocking one of those NaV subtypes reduces nociceptor excitability only if the other subtypes are weakly expressed. For example, excitability relies on NaV1.8 in acutely dissociated nociceptors but responsibility shifts to NaV1.7 and NaV1.3 by the fourth day in culture. A similar shift in NaV dependence occurs in vivo after inflammation, impacting ability of the NaV1.7-selective inhibitor PF-05089771 to reduce pain in behavioral tests. Flexible use of different NaV subtypes exemplifies degeneracy – achieving similar function using different components – and compromises reliable modulation of nociceptor excitability by subtype-selective inhibitors. Identifying the dominant NaV subtype to predict drug efficacy is not trivial. Degeneracy at the cellular level must be considered when choosing drug targets at the molecular level.